ESC 365 - Prevention of cardiotoxicity.

HFA Premium Access

Prevention of cardiotoxicity.

Session: Clinical approach to cardio-oncological patient

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Doctor K. Keramida (Athens, GR)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Kalliopi Keramida

Agios Savvas General Oncology Hospital, Athens (Greece)

9 presentations

2 followers

4 more presentations in this session

Early detection of cardio-toxicity: the role of imaging.

Speaker: Doctor T. Lopez Fernandez (Madrid, ES)

Early detection of cardio-toxicity: the role of biomarkers.

Speaker: Doctor D. Cardinale (Milan, IT)

Medical Interventions.

Speaker: Professor R. De Boer (Rotterdam, NL)

How to start a cardio-oncology service.

Speaker: Doctor A. Lyon (London, GB)

Access the full session

Clinical approach to cardio-oncological patient

Speakers: Doctor K. Keramida, Doctor T. Lopez Fernandez, Doctor D. Cardinale, Professor R. De Boer, Doctor A. Lyon

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources